Key Development Global biopharmaceutical major Bristol Myers Squibb (NYSE: BMY) has entered into a strategic discovery collaboration with biological AI... Read more
Category: Uncategorized
Advanced Biologics Testing & CMC Validation: Charles River Laboratories and Medigen Partner to Validate Virus Seed Bank for Next-Generation Multivalent Enterovirus Vaccine
Key Development Global non-clinical research and biologics testing provider Charles River Laboratories International, Inc. (NYSE: CRL) and Taiwan-based vaccine developer... Read more
Mass Tort Litigation Defense: Abbott Agrees to $670 Million Settlement to Resolve 2,000 Preterm Infant Formula Necrotizing Enterocolitis (NEC) Claims
Key Development Global healthcare and medical nutrition leader Abbott Laboratories (NYSE: ABT) announced on August 20, 2026, that it has... Read more
Mass Tort Litigation Defense: Abbott Agrees to $670 Million Settlement to Resolve 2,000 Preterm Infant Formula Necrotizing Enterocolitis (NEC) Claims
Key Development On August 20, 2026, global healthcare leader Abbott Laboratories (NYSE: ABT) formally announced a $670 million comprehensive settlement... Read more
Breakthrough in Personalized Oncology: Moderna and Merck’s Tailored mRNA Cancer Vaccine Intismeran Cuts Melanoma Recurrence and Metastasis in Landmark Phase 3 Trial – Moderna Shares Surge 160%
Key Development On August 19, 2026, Moderna (NASDAQ: MRNA) and Merck & Co. (NYSE: MRK) announced positive interim results from... Read more
CNS Patent Defense & Market Exclusivity: SK Biopharmaceuticals Reaches Landmark Patent Settlement with MSN Laboratories to Protect U.S. Exclusivity for Anti-Epileptic Blockbuster Xcopri® (Cenobamate) Beyond 2032
Key Development On August 19, 2026, South Korean biopharmaceutical leader SK Biopharmaceuticals (KRX: 326030) formally concluded its first patent litigation... Read more
Ultrarare Genetic Disease Milestone: FDA Approves Regeneron’s Pasatru® (Garetosmab) for Fibrodysplasia Ossificans Progressiva (FOP) – Delivering Up to 94% Reduction in New Heterotopic Bone Lesions
Key Development Following more than a decade of translational R&D, Regeneron Pharmaceuticals (NASDAQ: REGN) has secured landmark regulatory approval from... Read more
Health Supplement Advertising Compliance: Vietnam Food Safety Authority Mandates Urgent Hanoi Health Department Inspection into DK-Betics Gold for Misleading Curative Claims and Physician Imagery
Key Development On the evening of August 19, 2026, the Vietnam Food Safety Authority (VFA) under the Ministry of Health... Read more
Digital Health Marketing Enforcement: Vietnam Food Safety Authority Directs Hanoi Department of Health to Audit Misleading Advertising for DK-Betics Gold and Non Alco Lozenges
Key Development The Vietnam Food Safety Authority (VFA) under the Ministry of Health has officially issued an urgent regulatory directive... Read more









